Differentiation of Breast Cancer from Fibroadenoma with Dual-Echo Dynamic Contrast-Enhanced MRI

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Wang, Shiwei ^a   DelProposto, Zachary ^b   Wang, Haoyu ^c   Ding, Xuewei ^a   Ji, Conghua ^a   Wang, Bei ^a   Xu, Maosheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

^c PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; BLOOD VOLUME; BREAST BIOPSY; BREAST CANCER; BREAST FIBROADENOMA; BREAST SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DUAL ECHO DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROADENOMA; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REGIONAL BLOOD FLOW; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84879756481     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067731     Document Type: Article

References (25)

1. Kuhl CK, (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244: 672-691.
2. Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, et al. (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292: 2735-2742.
3. Peters NH, Borel RI, Zuithoff NP, Mali WP, Moons KG, et al. (2008) Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246: 116-124.
4. Moy L, Elias K, Patel V, Lee J, Babb JS, et al. (2009) Is breast MRI helpful in the evaluation of inconclusive mammographic findings? AJR Am J Roentgenol 193: 986-993.
5. Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, et al. (2009) Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol 70: 69-76.
6. Gilles R, Meunier M, Lucidarme O, Zafrani B, Guinebretiere JM, et al. (1996) Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 20: 9-14.
7. Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, et al. (2000) Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology 216: 545-553.
8. Benner T, Heiland S, Erb G, Forsting M, Sartor K, (1997) Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 15: 307-317.
9. Henderson E, Rutt BK, Lee TY, (1998) Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 16: 1057-1073.
10. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R, (1999) Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 19: 701-735.
11. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, et al. (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232: 585-591.
12. de Bazelaire C, Rofsky NM, Duhamel G, Zhang J, Michaelson MD, et al. (2006) Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol 16: 2083-2091.
13. Taillieu F, Salomon LJ, Siauve N, Clement O, Faye N, et al. (2006) Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice. Radiology 241: 737-745.
14. Ludemann L, Prochnow D, Rohlfing T, Franiel T, Warmuth C, et al. (2009) Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrast-enhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence. Ann Biomed Eng 37: 749-762.
15. Mussurakis S, Gibbs P, Horsman A, (1998) Primary breast abnormalities: selective pixel sampling on dynamic gadolinium-enhanced MR images. Radiology 206: 465-473.
16. Evelhoch JL, (1999) Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10: 254-259.
17. Liney GP, Gibbs P, Hayes C, Leach MO, Turnbull LW, (1999) Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semi-automated region-of-interest analysis. J Magn Reson Imaging 10: 945-949.
18. Barbier EL, Lamalle L, Decorps M, (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13: 496-520.
19. Yang X, Knopp MV, (2011) Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol 2011: 732848.
20. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch RC, (1993) Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 29: 616-622.
21. Kim EJ, Kim DH, Lee SH, Huh YM, Song HT, et al. (2004) Simultaneous acquisition of perfusion and permeability from corrected relaxation rates with dynamic susceptibility contrast dual gradient echo. Magn Reson Imaging 22: 307-314.
22. Makkat S, Luypaert R, Sourbron S, Stadnik T, De Mey J, (2007) Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data. J Magn Reson Imaging 25: 1159-1167.
23. Li J, Yu Y, Zhang Y, Bao S, Wu C, et al. (2009) A clinically feasible method to estimate pharmacokinetic parameters in breast cancer. Med Phys 36: 3786-3794.
24. Wang H, Miao Y, Zhou K, Yu Y, Bao S, et al. (2010) Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory. Med Phys 37: 4971-4981.
25. Yu Y, Jiang Q, Miao Y, Li J, Bao S, et al. (2010) Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer. Radiology 257: 47-55.